Creative Planning
CRBP icon

Creative Planning’s Corbus Pharmaceuticals CRBP Stock Holding History

Creative Planning’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,901
Closed -$22.9K – 2672
2022
Q4 		$22.9K Hold
6,901
– – ﹤0.01% 2307
2022
Q3 		$34K Hold
6,901
– – ﹤0.01% 2144
2022
Q2 		$52K Hold
6,901
– – ﹤0.01% 2046
2022
Q1 		$110K Hold
6,901
– – ﹤0.01% 1979
2021
Q4 		$127K Sell
6,901
-900
-12% -$24.4K ﹤0.01% 1930
2021
Q3 		$239K Sell
7,801
-133
-2% -$5.25K ﹤0.01% 1736
2021
Q2 		$436K Buy
7,934
+133
+2% +$7.38K ﹤0.01% 1355
2021
Q1 		$461K Hold
7,801
– – ﹤0.01% 1491
2020
Q4 		$293K Sell
7,801
-266
-3% -$9.95K ﹤0.01% 1648
2020
Q3 		$436K Buy
8,067
+956
+13% +$173K ﹤0.01% 1200
2020
Q2 		$1.79M Buy
7,111
+7
+0.1% +$1.42K 0.01% 536
2020
Q1 		$1.12M Buy
7,104
+354
+5% +$59.8K ﹤0.01% 603
2019
Q4 		$1.11M Buy
6,750
+117
+2% +$17.3K ﹤0.01% 743
2019
Q3 		$969K Sell
6,633
-4
-0.1% -$697 ﹤0.01% 775
2019
Q2 		$1.38M Sell
6,637
-1,291
-16% -$276K ﹤0.01% 624
2019
Q1 		$1.65M Buy
7,928
+1,276
+19% +$281K 0.01% 530
2018
Q4 		$1.17M Sell
6,652
-76
-1% -$15.2K ﹤0.01% 614
2018
Q3 		$1.52M Buy
6,728
+67
+1% +$10.8K 0.01% 564
2018
Q2 		$1.01M Buy
6,661
+40
+0.6% +$7.27K ﹤0.01% 745
2018
Q1 		$1.21M Buy
6,621
+653
+11% +$147K ﹤0.01% 637
2017
Q4 		$1.27M Buy
5,968
+162
+3% +$34.7K 0.01% 606
2017
Q3 		$1.25M Buy
5,806
+23
+0.4% +$4.5K 0.01% 619
2017
Q2 		$1.09M Buy
5,783
+218
+4% +$42.7K 0.01% 647
2017
Q1 		$1.38M Buy
5,565
+133
+2% +$32.6K 0.01% 555
2016
Q4 		$1.38M Sell
5,432
-20
-0.4% -$4.58K 0.01% 508
2016
Q3 		$1.11M Buy
5,452
+1,333
+32% +$166K 0.01% 556
2016
Q2 		$369K Buy
4,119
+4,016
+3,899% +$315K ﹤0.01% 923
2016
Q1 		$6K Buy
103
+33
+47% +$1.46K ﹤0.01% 3482
2015
Q4 		$3K Hold
70
– – ﹤0.01% 3893
2015
Q3 		$3K Buy
+70
New +$4.66K ﹤0.01% 3812

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Creative Planning's CRBP Position: Q1 2023 in Review

Creative Planning sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 6,901 shares — an estimated $22.9K sold.

Creative Planning first reported a position in CRBP in Q3 2015 and held it in 30 quarters. The position peaked at $1.79M in Q2 2020. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

  • Creative Planning reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Creative Planning sold 6,901 Corbus Pharmaceuticals shares in Q1 2023, an estimated $22.9K.
  • Creative Planning first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 30 quarters.
  • Creative Planning's Corbus Pharmaceuticals position peaked at $1.79M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.